26 May 2026 - Apotex today announced that Health Canada has approved Iheezo (chloroprocaine hydrochloride ophthalmic gel 3%), a topical ophthalmic anaesthetic indicated for ocular surface anaesthesia during ophthalmologic procedures in adults.

With approval granted, Iheezo will be available to Canadian health care professionals as a sterile, preservative‑free gel formulation supplied in single use vials. Iheezo is intended for administration by qualified eye care clinicians only and is not for patient self administration.

Read Apotex press release